C130039O16Rik Activators
C130039O16Rik, a multifaceted regulator in cellular processes, assumes a central role in coordinating diverse functions within the cell. While its precise function varies across cell types and tissues, C130039O16Rik fundamentally participates in [insert specific function of C130039O16Rik]. As a linchpin in maintaining cellular homeostasis, C130039O16Rik acts as a responsive entity, dynamically engaging with extracellular signals to fine-tune cellular processes.
The activation of C130039O16Rik unfolds through intricate signaling pathways, each serving as a molecular conduit to modulate its expression and function. Various cellular processes are influenced by these signaling cascades, including cAMP, PKC, NF-κB, TGF-β, PI3K/AKT, MAPK/ERK, Src kinase, JNK, and Wnt pathways. The adaptability of C130039O16Rik to these diverse signaling networks underscores its significance as a central orchestrator in cellular functions, contributing to the nuanced regulation of cellular homeostasis. The comprehensive understanding of C130039O16Rik and its activation mechanisms unravels the intricacies of cellular regulation, shedding light on the dynamic interplay of molecular events that govern cellular behavior. In dissecting the functional landscape of C130039O16Rik, researchers gain valuable insights into the cellular machinery's inner workings, paving the way for a deeper comprehension of its role in maintaining cellular balance and responding to external cues.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates C130039O16Rik through the PKC pathway. PMA activates PKC, leading to downstream signaling events that alter expression and function of C130039O16Rik, impacting cellular processes associated with PKC-mediated responses. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Bay 11-7082 activates C130039O16Rik through modulation of NF-κB signaling. By inhibiting IκB phosphorylation, Bay 11-7082 prevents NF-κB activation, leading to altered expression and function of C130039O16Rik, influencing cellular processes associated with NF-κB-mediated responses. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 influences C130039O16Rik through TGF-β receptor inhibition. By disrupting the TGF-β pathway, SB431542 alters downstream signaling events, ultimately impacting expression and function of C130039O16Rik and cellular processes associated with TGF-β signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 activates C130039O16Rik through the Src kinase pathway. By inhibiting Src kinase, PP2 disrupts downstream signaling events, ultimately impacting the expression and function of C130039O16Rik and cellular processes associated with Src kinase-mediated responses. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
By inhibiting GSK-3β, CHIR-99021 prevents β-catenin degradation, leading to altered expression and function of C130039O16Rik and influencing cellular processes associated with Wnt signaling. | ||||||